Hello @hncm, here is a very brief overview of the research you are referring to:

"Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy"
- https://www.jacc.org/doi/10.1016/j.jacc.2024.03.387
---------
"Ninerafaxstat in the Treatment of Diabetic Cardiomyopathy and Nonobstructive Hypertrophic Cardiomyopathy"
- https://pubmed.ncbi.nlm.nih.gov/39194232/
---------
As you mentioned, the study concluded that it be moved to a Phase 3, but finding exactly when is unclear. Have you had a chance to discuss this research with your provider to inquire about whether or not you can become part of the research?